Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Clinical trial NCT02283853 · COMPLETED

Trial details

NCT number: NCT02283853
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2014-08-28
Primary completion: 2025-07-08
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.